Examkin

Soru

Zorluk: ZorPharmacologic Interventions

A 32-year-old woman is brought to the emergency department via ambulance due to a witnessed generalized tonic-clonic seizure. Her partner reports that she has no history of seizures but complained of a severe headache earlier today. Paramedics report the seizure began 1515 minutes ago and has been continuous since their arrival. On presentation, she is unresponsive, actively convulsing with rhythmic extremity jerking, and frothing at the mouth. Vitals are temperature 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), pulse 135135/min, blood pressure 158/92158/92 mmHg, and oxygen saturation 92%92\% on a non-rebreather mask. Intravenous access is established.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the stepwise management of this patient's condition, from first-line therapy to treatments reserved for super-refractory disease.

  1. 1Intravenous lorazepam
  2. 2Intravenous fosphenytoin
  3. 3Intravenous propofol
  4. 4Intravenous pentobarbital

Cevap

The correct sequence for managing status epilepticus begins with a rapid-acting benzodiazepine (intravenous lorazepam), followed by a long-acting antiseizure medication (intravenous fosphenytoin), escalated to an anesthetic infusion (intravenous propofol) for refractory cases, and finally a barbiturate coma (intravenous pentobarbital) for super-refractory status.
Status epilepticus is defined as ≥5\ge 5 minutes of continuous clinical seizure activity or recurrent seizures without return to baseline. It requires a rigid, stepwise pharmacologic approach. Phase I (first-line) utilizes rapid-acting benzodiazepines (intravenous lorazepam, or intramuscular midazolam if IV access is unavailable) to immediately halt the seizure. Phase II (second-line) employs long-acting antiseizure medications (intravenous fosphenytoin, valproic acid, or levetiracetam) to prevent recurrence or treat established status. Phase III (third-line) involves anesthetic infusions (propofol or midazolam) for refractory status epilepticus, which necessitates endotracheal intubation. Finally, if the patient remains in super-refractory status epilepticus, a barbiturate coma using pentobarbital is initiated.

Adım Adım Çözüm

1
Identify the clinical emergency and immediate goal.
The patient is in generalized convulsive status epilepticus (continuous seizure > 5 minutes).
This is a neurologic emergency requiring immediate protocolized pharmacologic escalation to prevent irreversible neuronal injury and excitotoxicity.
2
Select the optimal first-line abortive therapy.
Intravenous lorazepam is selected as the initial intervention.
Highly lipid-soluble benzodiazepines cross the blood-brain barrier rapidly to terminate ongoing clinical seizures immediately.
3
Select the appropriate second-line therapy.
Intravenous fosphenytoin is selected next.
Regardless of whether the seizure stops after the benzodiazepine, a long-acting agent is required to prevent recurrence. If the seizure persists, it serves as the next abortive step.
4
Determine the third-line therapy for refractory status epilepticus.
Intravenous propofol is selected for step three.
When standard non-sedating agents fail, continuous anesthetic infusions (propofol or midazolam) are required. This step simultaneously requires definitive airway management (intubation).
5
Identify the final intervention for super-refractory status.
Intravenous pentobarbital is placed last.
Barbiturate coma is highly suppressive to both the cortex and the cardiovascular system, making it the intervention of absolute last resort when all other therapies fail.

Anahtar Kavram

Pharmacologic escalation algorithm for Status Epilepticus
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru